Stockscreener 앱 받기
1.48
0.67%
-0.01
시간 외 거래:
2.00
0.52
+35.14%
전일 마감가:
$1.49
열려 있는:
$1.5
하루 거래량:
7.53M
Relative Volume:
2.69
시가총액:
$47.78M
수익:
-
순이익/손실:
$-16.14M
주가수익비율:
-2.7407
EPS:
-0.54
순현금흐름:
$-3.99M
1주 성능:
+2.07%
1개월 성능:
-32.42%
6개월 성능:
-62.15%
1년 성능:
-71.86%
1일 변동 폭
$1.46
$1.51
1주일 범위
$1.4325
$1.51
52주 변동 폭
$1.12
$8.40
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
명칭
Telomir Pharmaceuticals Inc
전화
786-396-6723
주소
100 SE 2ND ST, MIAMI
TELO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.48 | 48.10M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-21 | 개시 | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스
Live market analysis of Telomir Pharmaceuticals Inc.GDP Growth & Weekly High Return Forecasts - Newser
How hedge fund analytics apply to Telomir Pharmaceuticals Inc. stock2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Earnings visualization tools for Telomir Pharmaceuticals Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
What candlestick patterns are forming on Telomir Pharmaceuticals Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
How institutional ownership impacts Telomir Pharmaceuticals Inc. stockShort Setup & Capital Efficient Trade Techniques - Newser
Using Python tools to backtest Telomir Pharmaceuticals Inc. strategiesMarket Growth Report & Community Verified Trade Alerts - Newser
Using economic indicators to assess Telomir Pharmaceuticals Inc. potentialTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
Can swing trading help recover from Telomir Pharmaceuticals Inc. losses2025 Top Gainers & Consistent Profit Alerts - Newser
What the charts say about Telomir Pharmaceuticals Inc. today2025 Retail Activity & Daily Momentum Trading Reports - Newser
Key metrics from Telomir Pharmaceuticals Inc.’s quarterly dataJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - Newser
What to expect from Telomir Pharmaceuticals Inc. in the next 30 daysWeekly Loss Report & Fast Moving Trade Plans - Newser
Telomir Pharmaceuticals Inc. stock trend forecastPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Published on: 2025-08-26 14:13:01 - Newser
Is Telomir Pharmaceuticals Inc. forming a reversal patternMarket Performance Report & AI Enhanced Market Trend Forecasts - Newser
Is Telomir Pharmaceuticals Inc. stock a hidden gemJuly 2025 Summary & Long-Term Capital Growth Ideas - sundaytimes.kr
Telomir Pharmaceuticals Inc. stock volume spike explainedPrice Action & Risk Managed Investment Signals - Newser
Is Telomir Pharmaceuticals Inc. the Top Chart Pick This WeekTrade Ideas & Fast Exit Strategy with Risk Control - 더경남뉴스
Visual trend scoring systems applied to Telomir Pharmaceuticals Inc.Earnings Recap Summary & High Return Stock Watch Alerts - Newser
Can machine learning forecast Telomir Pharmaceuticals Inc. recoveryMarket Sentiment Report & High Accuracy Swing Entry Alerts - Newser
What drives Telomir Pharmaceuticals Inc.’s stock pricePortfolio Update Report & Weekly Watchlist of Top Performers - theviewers.co.kr
Is Telomir Pharmaceuticals Inc. still worth holding after the dipWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Real time social sentiment graph for Telomir Pharmaceuticals Inc.Buy Signal & Low Risk High Reward Ideas - Newser
Is There Enough Volume to Lift Telomir Pharmaceuticals Inc.Market Performance Recap & Expert Curated Trade Setup Alerts - beatles.ru
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - Worcester Telegram
What recovery options are there for Telomir Pharmaceuticals Inc.2025 Price Action Summary & Free Technical Pattern Based Buy Signals - Newser
Statistical indicators supporting Telomir Pharmaceuticals Inc.’s strengthMarket Weekly Review & Low Risk Growth Stock Ideas - Newser
Telomir Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Gainers & Long-Term Safe Investment Ideas - Newser
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeriaan Ultra-Rare Genetic Disorder that Causes Rapid Aging - The Florida Times-Union
Will Telomir Pharmaceuticals Inc. outperform the marketDollar Strength & Safe Investment Capital Preservation Plans - Newser
Telomir Pharmaceuticals Inc (TELO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):